Stent with drug coating with variable release rate

• US 8,628,568 B2
• Filed: 01/08/2010
• Issued: 01/14/2014
• Est. Priority Date: 11/12/2002
• Status: Active Grant

• Current Assignee: Abbott Cardiovascular Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Cardiovascular Systems Incorporated (Abbott Laboratories Incorporated)
• Inventors: Santos, Veronica J., Prabhu, Santosh
• Primary Examiner(s): Stewart, Alvin J.
• Application Number:
  US12/684,644
• Publication Number:
  US 20100131046A1
• Time in Patent Office: 1,467 Days
• Field of Search: 623 139- 146, 623/1.13, 623/1.35
• US Class Current: 623/1.42
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/91533 characterised by the phase between adjacent bands
• CPC Class Codes: A61F 2002/91575 connected peak to trough
• CPC Class Codes: A61F 2250/0068 the pharmaceutical product being in a reservoir

Abstract

A stent is provided with a coating having a variable drug release rate. The release rate can be greater over a curved or bent segment of a strut network as compared to generally linear segments of the strut network. The coating can have a barrier region that is thicker over the generally linear segments. The coating can have a drug mixed with polymers. The curved or bent segment can have a greater amount of a polymer having relatively high drug permeability as compared to the generally linear segments.

Claims

1. A strut network for a radially expandable stent, comprising:

generally linear segments interrupted by a curved or bent segment; and

a surface coating containing a drug disposed on the generally linear segments and on the curved or bent segment, wherein a release rate of the drug from the surface coating is greater in the curved or bent segment as compared to the generally linear segments,

wherein a concentration of the drug in the surface coating is substantially the same over the generally linear segments and the curved or bent segment, the concentration is the amount of drug per amount of surface coating, and

wherein the strut network further comprises a proximal end, a distal end, and an intermediate portion connecting the proximal end to the distal end, and the curved or bent segment and the generally linear segments are disposed within the intermediate portion.

2. The strut network of claim 1, further comprising a reservoir region containing the drug and a barrier region disposed over the reservoir region, the thickness of the barrier region is greater at the generally linear segments than at the curved or bent segment.

3. The strut network of claim 2, wherein the concentration of the drug in the reservoir region is substantially the same over the generally linear segments and the curved or bent segment.

4. The strut network of claim 1, wherein the drug is mixed or dispersed in a first polymer for the curved or bent segment and in a second polymer for the generally linear segments, wherein the first polymer has a greater drug permeability than the second polymer.

5. The strut network of claim 1, wherein the drug is mixed or dispersed in a mixture of a first polymer and a second polymer, the first polymer having a greater drug permeability than the second polymer.

6. The strut network of claim 1, wherein three of the generally linear segments meet and come together at the curved or bent segment, one of the three generally linear segments being disposed between the other two of the three generally linear segments.

7. The strut network of claim 1, wherein the generally linear segments converge at a plurality of curved or bent segments.

8. The strut network of claim 1, wherein the release rate gradually changes from the generally linear segments to the curved or bent segment.

9. A strut network for a radially expandable stent, comprising:

generally linear segments interrupted by a curved or bent segment; and

a surface coating containing a drug disposed on the generally linear segments and on the curved or bent segment, wherein a release rate of the drug from the surface coating is greater in the curved or bent segment as compared to the generally linear segments,

wherein a thickness of the surface coating is greater at the generally linear segments than at the curved or bent segment, a concentration of the drug in the surface coating is substantially the same over the generally linear segments and the curved or bent segment, the concentration is the amount of drug per amount of surface coating, and

wherein the strut network further comprises a proximal end, a distal end, and an intermediate portion connecting the proximal end to the distal end, and the curved or bent segment and the generally linear segments are disposed within the intermediate portion.

10. The strut network of claim 9, wherein the thickness of the surface coating gradually changes from the generally linear segments to the curved or bent segment.

11. The strut network of claim 9, wherein the surface coating comprises a reservoir region containing the drug and a barrier region disposed over the reservoir region, and a thickness of the barrier region is greater at the generally linear segments than at the curved or bent segment.

12. A strut network for a radially expandable stent, comprising:

generally linear segments interrupted by a curved or bent segment; and

a surface coating containing a drug disposed on the generally linear segments and on the curved or bent segment, wherein a release rate of the drug from the surface coating is greater in the curved or bent segment as compared to the generally linear segments,

wherein a concentration of the drug in the surface coating is substantially the same over the generally linear segments and the curved or bent segment, the concentration is the amount of drug per amount of surface coating,

wherein the drug is mixed or dispersed in a mixture of a first polymer and a second polymer, the first polymer having a greater drug permeability than the second polymer, and

wherein the mixture, for the curved or bent segment, has a greater proportion of the first polymer than the second polymer.

13. A strut network for a radially expandable stent, comprising:

generally linear segments interrupted by a curved or bent segment; and

a surface coating containing a drug disposed on the generally linear segments and on the curved or bent segment, wherein a release rate of the drug from the surface coating is greater in the curved or bent segment as compared to the generally linear segments,

wherein a concentration of the drug in the surface coating is substantially the same over the generally linear segments and the curved or bent segment, the concentration is the amount of drug per amount of surface coating,

wherein the drug is mixed or dispersed in a mixture of a first polymer and a second polymer, the first polymer having a greater drug permeability than the second polymer, and

wherein the mixture, for the generally linear segments, has a lesser proportion of the first polymer than the second polymer.

14. A strut network for a radially expandable stent, comprising:

generally linear segments interrupted by a curved or bent segment; and

a surface coating containing a drug disposed on the generally linear segments and on the curved or bent segment, wherein a release rate of the drug from the surface coating is greater in the curved or bent segment as compared to the generally linear segments,

wherein a concentration of the drug in the surface coating is substantially the same over the generally linear segments and the curved or bent segment, the concentration is the amount of drug per amount of surface coating, and

wherein the release rate of the drug from the surface coating is greatest at the vertex of the curved or bent segment as compared to other portions of the curved or bent segment.

15. The strut network of claim 14, wherein the surface coating comprises a reservoir region containing the drug and a barrier region disposed over the reservoir region, and a thickness of the barrier region is greater at the generally linear segments than at the curved or bent segment.

16. The strut network of claim 15, wherein the concentration of the drug in the reservoir region is substantially the same over the generally linear segments and the curved or bent segment.